# Clinical Efficacy and Safety of Microwave Ablation Combined With Huaier Granules in Patients With Inoperable Stage IA Non-Small Cell Lung Cancer: A Prospective, Single-Center, Randomized Controlled Clinical Trial

> **NCT07197853** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Xin Ye** · enrollment: 180 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer (NSCLC)
- Huaier Granules
- Microwave Ablation

## Interventions

- **DRUG:** Huaier Granule

## Key facts

- **NCT ID:** NCT07197853
- **Lead sponsor:** Xin Ye
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10-01
- **Primary completion:** 2028-06-30
- **Final completion:** 2028-06-30
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2025-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07197853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07197853, "Clinical Efficacy and Safety of Microwave Ablation Combined With Huaier Granules in Patients With Inoperable Stage IA Non-Small Cell Lung Cancer: A Prospective, Single-Center, Randomized Controlled Clinical Trial". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07197853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*